| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.24 | 0.02 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.15 | 0.6 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.3 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.13 | 0.006 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.5 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.1 | 0.06 |